Sigyn Therapeutics, Inc. (SIGY)

Market Cap	74.68K -99.8%
Revenue (ttm)	n/a
Net Income	-3.22M
EPS	-2.01
Shares Out	1.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,940
Average Volume	22,904
Open	0.0600
Previous Close	0.0580
Day's Range	0.0460 - 0.0600
52-Week Range	0.0450 - 5.0000
Beta	-0.69
RSI	30.30
Earnings Date	Feb 19, 2026

About Sigyn Therapeutics

Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community-acquired pneumonia, drug-resistant bacterial infections, and emerging pandemic threats. The company is also involved in the evaluation of Sig...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: SIGY